Philip Morris has trailed behind the Dow Jones Industrial Average over the past year, and analysts remain moderately optimistic about the stock’s prospects.
Transaction Addresses Capital Structure and Supports Near-Term Operating Priorities, Including Anticipated CMMI Medicare Pilot Program Participation
With the S&P 500 breaking below its 200-day SMA, high-yield dividend stocks are increasingly worth considering as a source of income and portfolio protection.
Philip Morris has outpaced the Nasdaq recently, and analysts remain moderately optimistic about the stock’s prospects.
ISSUED ON BEHALF OF DOSEOLOGY SCIENCES INC. VANCOUVER – Baystreet.ca News Commentary – The energy and nicotine markets are slamming together in a massive structural shift that is accelerating...
The consumer staples sector is a popular hideout for investors during volatile markets. Consider these three stocks to strengthen your portfolio.
Altria has significantly trailed the broader market over the past year, leading analysts to take a more guarded stance on the stock.